The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Stromal biology and therapy in pancreatic cancer
Abstract
Pancreatic ductal adenocarcinoma (PDA) is an almost uniformly lethal disease. One explanation for the devastating prognosis is the failure of many chemotherapies, including the current standard of care therapy gemcitabine. Although our knowledge of the molecular events underlying multistep carcinogenesis in PDA has steadily increased, translation into more effective therapeutic approaches has been inefficient over the last several decades. Evidence for this innate resistance to systemic therapies was recently provided in an accurate mouse model of PDA by the demonstration that chemotherapies are poorly delivered to PDA tissues because of a deficient vasculature. This vascular deficiency correlated with the presence of a dense stromal matrix that is a prominent histological hallmark of PDA tumours. Therapeutic targeting of stromal cells decreased the stroma from pancreatic tumours, resulting in increased intratumoral perfusion and therapeutic delivery of gemcitabine. Stromal cells contained within the PDA tumour microenvironment therefore represent an additional constituent to neoplastic cells that should be critically evaluated for optimal therapeutic development in preclinical models and early clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citationStromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Castillo, C. F.-D., Yajnik, V., et al. (2003) · Nature · doi:10.1038/nature02009 · Cited by 1,480
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
Hwang, R. F., Moore, T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A., Ji, B., Evans, D. B., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5714 · Cited by 1,099
Identification, culture, and characterization of pancreatic stellate cells in rats and humans
Bachem, M. G., Schneider, E., Groß, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H., Grünert, A., & Adler, G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70209-4 · Cited by 1,018
A paracrine requirement for hedgehog signalling in cancer
Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T., Tian, H., Ahn, C. P., Marshall, D., Fu, L., Januario, T., Kallop, D., et al. (2008) · Nature · doi:10.1038/nature07275 · Cited by 961
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M. G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.023 · Cited by 950
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture
Apte, M. V., Haber, P. S., Applegate, T. L., Norton, I. D., McCaughan, G. W., Korsten, M. A., Pirola, R. C., & Wilson, J. S. (1998) · Gut · doi:10.1136/gut.43.1.128 · Cited by 918
Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 1×
“After decades of intensive efforts in genomic research focusing on molecular alterations in tumour cells,”
BackgroundCunningham, D., Chau, I., Stocken, D. D., Valle, J. W., Smith, D., Steward, W., Harper, P. G., Dunn, J., Tudur-Smith, C., West, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2446 · Cited by 823
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Prognostic indicators for survival after resection of pancreatic adenocarcinoma
Geer, R. J., & Brennan, M. F. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80406-4 · Cited by 764
Berlin, J. D., Catalano, P., Thomas, J. P., Kugler, J. W., Haller, D. G., & Benson, A. B. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.149 · Cited by 729
The pancreatic stellate cell: a star on the rise in pancreatic diseases
Omary, M. B., Lugea, A., Lowe, A. W., & Pandol, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30082 · Cited by 692
Heinemann, V., Quietzsch, D., Gieseler, F., Gonnermann, M., Schönekäs, H., Rost, A., Neuhaus, H., Haag, C., Clemens, M., Heinrich, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1490 · Cited by 683
Bachem, M. G., Schünemann, M., Ramadani, M., Siech, M., Beger, H., Buck, A., Zhou, S., Schmid-Kotsas, A., & Adler, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.036 · Cited by 657
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M., Campone, M., Brain, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1908 · Cited by 623
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Von Hoff, D. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 601
Herrmann, R., Bodoky, G., Ruhstaller, T., Glimelius, B., Bajetta, E., Schüller, J., Saletti, P., Bauer, J., Figer, A., Pestalozzi, B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0886 · Cited by 595
Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells
Apte, M. V., Park, S., Phillips, P. A., Santucci, N., Goldstein, D., Kumar, R. K., Ramm, G. A., Buchler, M., Friess, H., McCarroll, J. A., et al. (2004) · Pancreas · doi:10.1097/00006676-200410000-00002 · Cited by 591 · cited 2×
“Upon activation by growth factors, cytokines or oxidant stress, PSCs transform into a myofibroblast-like phenotype and secrete excessive amounts of collagen I, III, fibronectin and matrix degrading enzymes such as MMPs.48 Figure 2 shows immunofluorescence stains of cultured primary human PSCs. Notably, several studies…”
BackgroundRocha Lima, C. M., Green, M. R., Rotche, R., Miller, W. H., Jeffrey, G. M., Cisar, L. A., Morganti, A., Orlando, N., Gruia, G., & Miller, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.082 · Cited by 588
Bramhall, S. R., Schulz, J., Nemunaitis, J., Brown, P. D., Baillet, M., & Buckels, J. A. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600446 · Cited by 557
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffery, T., Ouellette, M. M., & Hollingsworth, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0291 · Cited by 519
Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
Vonlaufen, A., Joshi, S., Qu, C., Phillips, P. A., Xu, Z., Parker, N. R., Toi, C. S., Pirola, R. C., Wilson, J. S., Goldstein, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2477 · Cited by 477
Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
Kindler, H. L., Friberg, G., Singh, D. A., Locker, G., Nattam, S., Kozloff, M., Taber, D. A., Karrison, T., Dachman, A., Stadler, W. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9661 · Cited by 460
Bramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Poplin, E., Feng, Y., Berlin, J., Rothenberg, M. L., Hochster, H., Mitchell, E., Alberts, S., O'Dwyer, P., Haller, D., Catalano, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9007 · Cited by 438
Erkan, M., Michalski, C. W., Rieder, S., Reiser–Erkan, C., Abiatari, I., Kolb, A., Giese, N. A., Esposito, I., Friess, H., & Kleeff, J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.05.006 · Cited by 424
Hruban, R. H., Adsay, N. V., Albores-Saavedra, J., Anver, M. R., Biankin, A. V., Boivin, G. P., Furth, E. E., Furukawa, T., Klein, A., Klimstra, D. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2168 · Cited by 414
Self-citationAn In vivo Platform for Translational Drug Development in Pancreatic Cancer
Rubio-Viqueira, B., Jimeno, A., Cusatis, G., Zhang, X., Iacobuzio-Donahue, C., Karikari, C., Shi, C., Danenberg, K., Danenberg, P. V., Kuramochi, H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0113 · Cited by 414
Infante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. A., Yeo, C., Iacobuzio-Donahue, C., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 406
Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis
Tian, H., Callahan, C. A., DuPree, K. J., Darbonne, W. C., Ahn, C. P., Scales, S. J., & de Sauvage, F. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813203106 · Cited by 404
Moinfar, F., Man, Y., Arnould, L., Bratthauer, G. L., Ratschek, M., & Tavassoli, F. A. (2000) · PubMed · Cited by 403
Seo, Y., Baba, H., Fukuda, T., Takashima, M., & Sugimachi, K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2239::aid-cncr6>3.0.co;2-v · Cited by 400
Moore, M. J., Hamm, J., Dancey, J., Eisenberg, P. D., Dagenais, M., Fields, A., Hagan, K., Greenberg, B., Colwell, B., Zee, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.098 · Cited by 396
Colucci, G., Giuliani, F., Gebbia, V., Biglietto, M., Rabitti, P., Uomo, G., Cigolari, S., Testa, A., Maiello, E., & Lopez, M. (2002) · PubMed · Cited by 384
Genetic progression in the pancreatic ducts
Hruban, R. H., Wilentz, R. E., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65054-7 · Cited by 373 · cited 1×
“On the basis of these histopathological and molecular studies, a model similar to that of the adenoma-carcinoma sequence in the development of colon cancer(11) was proposed to describe the progression from normal pancreas via preneoplastic lesions to invasive cancer.(9) According to their stepwise accumulation of hist…”
MethodShekhar, M. P. V., Werdell, J., Santner, S. J., Pauley, R. J., & Tait, L. R. (2001) · PubMed · Cited by 327
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Stromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 317
Oettle, H., Richards, D., Ramanathan, R. K., van Laethem, J. L., Peeters, M., Fuchs, M., Zimmermann, A., John, W., Von Hoff, D., Arning, M., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi309 · Cited by 306
Erkan, M., Kleeff, J., Gorbachevski, A., Reiser, C., Mitkus, T., Esposito, I., Giese, T., Büchler, M. W., Giese, N. A., & Friess, H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.031 · Cited by 305
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
Patocs, A., Zhang, L., Xu, Y., Weber, F., Caldes, T., Mutter, G. L., Platzer, P., & Eng, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071825 · Cited by 297
Phillips, P. A. (2003) · Gut · doi:10.1136/gut.52.2.275 · Cited by 295
Erkan, M., Reiser-Erkan, C., Michalski, C. W., Deucker, S., Sauliunaite, D., Streit, S., Esposito, I., Friess, H., & Kleeff, J. (2009) · Neoplasia · doi:10.1593/neo.81618 · Cited by 291
Abou-Alfa, G. K., Letourneau, R., Harker, G., Modiano, M., Hurwitz, H., Tchekmedyian, N. S., Feit, K., Ackerman, J., De Jager, R. L., Eckhardt, S. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0201 · Cited by 282
Koenig, A., Mueller, C., Hasel, C., Adler, G., & Menke, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2804 · Cited by 277
Pancreatic cancer–associated stroma production
Korc, M. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.05.004 · Cited by 268
Spano, J.-P., Chodkiewicz, C., Maurel, J., Wong, R., Wasan, H., Barone, C., Létourneau, R., Bajetta, E., Pithavala, Y., Bycott, P., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60661-3 · Cited by 250
Ueda, S., Ogata, S., Tsuda, H., Kawarabayashi, N., Kimura, M., Sugiura, Y., Tamai, S., Matsubara, O., Hatsuse, K., & Mochizuki, H. (2004) · Pancreas · doi:10.1097/00006676-200407000-00061 · Cited by 245
Kindler, H. L., Niedzwiecki, D., Hollis, D., Oraefo, E., Schrag, D., Hurwitz, H., McLeod, H. L., Mulcahy, M. F., Schilsky, R. L., & Goldberg, R. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4508 · Cited by 235
Stathopoulos, G. P., Syrigos, K., Aravantinos, G., Polyzos, A., Papakotoulas, P., Fountzilas, G., Potamianou, A., Ziras, N., Boukovinas, J., Varthalitis, J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603301 · Cited by 198
Komar, G., Kauhanen, S., Liukko, K., Seppänen, M., Kajander, S., Ovaska, J., Nuutila, P., & Minn, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0414 · Cited by 176
Walter, K., Omura, N., Hong, S.-M., Griffith, M., Vincent, A., Borges, M., & Goggins, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1913 · Cited by 172
Vitamin A‐Storing Cells (Stellate Cells)
Senoo, H., Kojima, N., & Sato, M. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75006-3 · Cited by 169
Inflammatory Mechanisms Contributing to Pancreatic Cancer Development
Farrow, B., Sugiyama, Y., Chen, A., Uffort, E., Nealon, W., & Mark Evers, B. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128681.76786.07 · Cited by 168
Sato, N., Maehara, N., & Goggins, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0677 · Cited by 159
Shu, Q., Wong, K., Su, J. M. F., Adesina, A. M., Yu, L. T., Tsang, Y. T. M., Antalfy, B., Baxter, P. A., Perlaky, L., Yang, J., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1009 · Cited by 152
Ide, T., Kitajima, Y., Miyoshi, A., Ohtsuka, T., Mitsuno, M., Ohtaka, K., Koga, Y., & Miyazaki, K. (2006) · International Journal of Cancer · doi:10.1002/ijc.22178 · Cited by 129
Schneiderhan, W., Díaz, F., Fundel, M., Zhou, S., Siech, M., Hasel, C., Möller, P., Gschwend, J. E., Seufferlein, T. T. W., Gress, T. M., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03347 · Cited by 124
Self-citationBuchholz, M., Kestler, H. A., Holzmann, K., Ellenrieder, V., Schneiderhan, W., Siech, M., Adler, G., Bachem, M. G., & Gress, T. M. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0680-2 · Cited by 124
Self-citationPancreatic stellate cells—role in pancreas cancer
Bachem, M. G., Zhou, S., Buck, K., Schneiderhan, W., & Siech, M. (2008) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-008-0279-5 · Cited by 123
Mantoni, T. S., Schendel, R. R. E., Rödel, F., Niedobitek, G., Al‐Assar, O., Masamune, A., & Brunner, T. B. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.11.6846 · Cited by 109
Molecular genetic basis of pancreatic adenocarcinoma
Hilgers, W., & Kern, S. E. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199909)26:1<1::aid-gcc1>3.0.co;2-x · Cited by 105
Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
Reiser–Erkan, C., Erkan, M., Zheng, P., Békási, S., Giese, N. A., Streit, S., Michalski, C. W., Friess, H., & Kleeff, J. H. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6418 · Cited by 102
The Molecular Basis of Pancreatic Fibrosis
Binkley, C. E., Zhang, L., Greenson, J. K., Giordano, T. J., Kuick, R. D., Misek, D., Hanash, S., Logsdon, C. D., & Simeone, D. M. (2004) · Pancreas · doi:10.1097/00006676-200411000-00003 · Cited by 102
Bramhall, S. R., Stamp, G., Dunn, J., Lemoine, N. R., & Neoptolemos, J. P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.190 · Cited by 93
Management strategies for patients with hereditary pancreatic cancer
Brentnall, T. A. (2005) · Current Treatment Options in Oncology · doi:10.1007/s11864-005-0046-6 · Cited by 85
Vaquero, E. C., Edderkaoui, M., Nam, K. J., Gukovsky, I., Pandol, S. J., & Gukovskaya, A. S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01203-4 · Cited by 83
Role of Extracellular Matrix in Pancreatic Diseases
Gress, T. M., Menke, A., Bachem, M. G., Müller-Pillasch, F., Ellenrieder, V., Weidenbach, H., Wagner, M., & Adler, G. (1998) · Digestion · doi:10.1159/000007567 · Cited by 69
Self-citationEpidermal growth factor receptor regulates pancreatic fibrosis
Blaine, S. A., Ray, K. C., Branch, K. M., Robinson, P. S., Whitehead, R. H., & Means, A. L. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00152.2009 · Cited by 66
Bocci, G., Danesi, R., Marangoni, G., Fioravanti, A., Boggi, U., Esposito, I., Fasciani, A., Boschi, E., Campani, D., Bevilacqua, G., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.062 · Cited by 49
The use of GEM models for experimental cancer therapeutics
Gopinathan, A., & Tuveson, D. A. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000570 · Cited by 47
Self-citationSuccessful xenografting of cryopreserved primary pancreatic cancers
Sorio, C., Bonora, A., Orlandini, S., Moore, P. S., Capelli, P., Cristofori, P. G., Negro, G. D., Marchiori, P. N., Gaviraghi, G., Falconi, M., et al. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000343 · Cited by 35
Guturu, P., Shah, V. H., & Urrutia, R. A. (2009) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-009-9071-1 · Cited by 20
Research works printed but not linked: 10
- Rothenberg, 1996, A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer, Ann Oncol, 7, 347, 10.1093/oxfordjournals.annonc.a010600 · doi:10.1093/oxfordjournals.annonc.a010600
- Crist, 1987, Improved hospital morbidity, mortality, and survival after the Whipple procedure, Ann Surg, 206, 358, 10.1097/00000658-198709000-00014 · doi:10.1097/00000658-198709000-00014
- Trede, 1990, Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality, Ann Surg, 211, 447, 10.1097/00000658-199004000-00011 · doi:10.1097/00000658-199004000-00011
- 10.1007/s11938-005-0039-3 · DOI
- 10.1111/j.1749-6632.1999.tb09533.x · doi:10.1111/j.1749-6632.1999.tb09533.x
- 10.1002/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.0.CO;2-O · doi:10.1002/(sici)1097-0215(20000101)85:1<14::aid-ijc3>3.0.co;2-o
- Buchholz, 2003, SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo, Cancer Res, 63, 4945
- 10.1016/j.bbrc.2004.08.229 · doi:10.1016/j.bbrc.2004.08.229
- 10.1159/000107400 · DOI
- 10.1002/cncr.10323 · DOI · Paper page
Cited by
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
“It is tempting to speculate that KrasG12D may promote the paracrine secretion of prostromal factors such as Sonic Hedgehog (Neesse et al., 2011); however, further work will be necessary to define this complex relationship.”
Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
The Pancreas Cancer Microenvironment
Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316
Self-citationVon Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., Korn, R. L., Desai, N., Trieu, V., Iglesias, J. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5742 · Cited by 1,044
Metadata
- Authors
- Neesse, A., Michl, P., Frese, K. K., Feig, C., Cook, N., Jacobetz, M. A., Lolkema, M. P., Buchholz, M., Olive, K. P., Gress, T. M., & Tuveson, D. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-10-21
- Volume
- 60
- Issue
- 6
- Pages
- 861-868
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2131070390
- Cited by
- 757
- References
- 87
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.